{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:04Z","timestamp":1788922144490,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03138-w","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T09:27:20Z","timestamp":1766741240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antitumor effects of morphine and tramadol on lung metastasis of melanoma tumor cells in vitro and in vivo"],"prefix":"10.1007","volume":"43","author":[{"given":"Thamires Barreto","family":"Sancho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Katarina Menezes","family":"da Cruz Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Ferreira Concei\u00e7\u00e3o","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Fernanda","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Medeiros","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Alexandre Oliveira","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"da Cunha Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105479","volume":"18","author":"M Dildar","year":"2021","unstructured":"Dildar M, et al. Skin cancer detection: a review using deep learning techniques. Int J Environ Res Public Health. 2021;18:5479. https:\/\/doi.org\/10.3390\/ijerph18105479.","journal-title":"Int J Environ Res Public Health"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20:1366\u201379. https:\/\/doi.org\/10.1080\/15384047.2019.1640032.","journal-title":"Cancer Biol Ther"},{"key":"3138_CR3","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMra2034861","volume":"384","author":"BD Curti","year":"2021","unstructured":"Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384:2229\u201340. https:\/\/doi.org\/10.1056\/NEJMra2034861.","journal-title":"N Engl J Med"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s11912-024-01557-y","volume":"26","author":"R Bliley","year":"2024","unstructured":"Bliley R, et al. Radiation and melanoma: where are we now? Curr Oncol Rep. 2024;26:904\u201314. https:\/\/doi.org\/10.1007\/s11912-024-01557-y.","journal-title":"Curr Oncol Rep"},{"key":"3138_CR5","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.123463","volume":"12","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, et al. The influence of analgesic modalities on postoperative cancer recurrence. Anesthesiol Pain Med. 2022;12:e123463. https:\/\/doi.org\/10.5812\/aapm.123463.","journal-title":"Anesthesiol Pain Med"},{"key":"3138_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012592.pub2","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, et al. Opioids for cancer pain\u2014an overview of cochrane reviews. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD012592.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1248\/bpb.b17-00215","volume":"40","author":"Y Chen","year":"2017","unstructured":"Chen Y, et al. Morphine can inhibit the growth of breast cancer MCF-7 cells by arresting the cell cycle and inducing apoptosis. Biol Pharm Bull. 2017;40:1686\u201392. https:\/\/doi.org\/10.1248\/bpb.b17-00215.","journal-title":"Biol Pharm Bull"},{"key":"3138_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1003466.","journal-title":"N Engl J Med"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, et al. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2019;381:1535\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1910836.","journal-title":"N Engl J Med"},{"key":"3138_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108312","volume":"241","author":"Y Noufal","year":"2023","unstructured":"Noufal Y, et al. Pharmacological data science perspective on fatal incidents of morphine treatment. Pharmacol Ther. 2023;241:108312. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108312.","journal-title":"Pharmacol Ther"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12094-017-1796-x","volume":"20","author":"XY Zhang","year":"2018","unstructured":"Zhang XY, et al. Morphine: double-faced roles in the regulation of tumor development. Clin Transl Oncol. 2018;20:808\u201314. https:\/\/doi.org\/10.1007\/s12094-017-1796-x.","journal-title":"Clin Transl Oncol"},{"key":"3138_CR12","first-page":"4491","volume":"62","author":"K Gupta","year":"2002","unstructured":"Gupta K, et al. Morphine stimulates angiogenesis and promotes breast tumor growth. Can Res. 2002;62:4491\u20138.","journal-title":"Can Res"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10585-013-9616-3","volume":"31","author":"B Afsharimani","year":"2014","unstructured":"Afsharimani B, et al. Morphine and breast tumor metastasis: the role of matrix-degrading enzymes. Clin Exp Metas. 2014;31:149\u201358. https:\/\/doi.org\/10.1007\/s10585-013-9616-3.","journal-title":"Clin Exp Metas"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.201700546R","volume":"31","author":"N Xie","year":"2017","unstructured":"Xie N, et al. Morphine alters the circulating proteolytic profile in mice. FASEB J. 2017;31:5208\u201316. https:\/\/doi.org\/10.1096\/fj.201700546R.","journal-title":"FASEB J"},{"key":"3138_CR15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s40265-021-01515-z","volume":"81","author":"LRV Roulet","year":"2021","unstructured":"Roulet LRV, Desmeules J, Piguet V. Tapentadol versus tramadol. Drugs. 2021;81:1257\u201372. https:\/\/doi.org\/10.1007\/s40265-021-01515-z.","journal-title":"Drugs"},{"key":"3138_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010099","author":"LC Liu","year":"2023","unstructured":"Liu LC, et al. Mitochondrial dysfunction in the cytotoxicity of tramadol in carcinoma cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24010099.","journal-title":"Int J Mol Sci"},{"key":"3138_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/rapm-2023-104511","volume":"49","author":"T Kuramochi","year":"2024","unstructured":"Kuramochi T, et al. Effects of tramadol on pancreatic adenocarcinoma. Reg Anesth Pain Med. 2024;49:200\u20138. https:\/\/doi.org\/10.1136\/rapm-2023-104511.","journal-title":"Reg Anesth Pain Med"},{"key":"3138_CR18","first-page":"2575","volume":"20","author":"M Xia","year":"2016","unstructured":"Xia M, Tong JH, Jl NN, Duan ML, Tan YH, Xu JG. Tramadol regulates proliferation, migration and invasion via PTEN\/PI3K\/AKT signaling in lung adenocarcinoma cells. Eur Ver Med Pharmacol Sci. 2016;20:2575\u201380.","journal-title":"Eur Ver Med Pharmacol Sci"},{"key":"3138_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4149\/BLL_2018_043","volume":"119","author":"S Haghjooy-Javanmard","year":"2018","unstructured":"Haghjooy-Javanmard S, et al. Influence of morphine on TLR4\/NF-\u03baB signaling. Bratisl Med J. 2018;119:229\u201333. https:\/\/doi.org\/10.4149\/BLL_2018_043.","journal-title":"Bratisl Med J"},{"key":"3138_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142735.im2001s39","volume":"20","author":"WW Overwijk","year":"2001","unstructured":"Overwijk WW, Restifo NP. B16 as a mouse model for human melanoma. Curr Protoc Immunol. 2001;20:1\u201333. https:\/\/doi.org\/10.1002\/0471142735.im2001s39.","journal-title":"Curr Protoc Immunol"},{"key":"3138_CR21","first-page":"1932","volume":"31","author":"W Lintz","year":"1981","unstructured":"Lintz W, et al. Biotransformation of tramadol in man and animal. Arzneimittelforschung. 1981;31:1932\u201343.","journal-title":"Arzneimittelforschung"},{"key":"3138_CR22","first-page":"157","volume":"20","author":"M Xia","year":"2016","unstructured":"Xia M, et al. Tramadol inhibits proliferation via \u03b12-adrenoceptor signaling. Eur Rev Med Pharmacol Sci. 2016;20:157\u201365.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3138_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-2125.2000.00141.x","volume":"49","author":"R Stuart-Harris","year":"2000","unstructured":"Stuart-Harris R, et al. Pharmacokinetics of morphine after subcutaneous injection. J Clin Pharmacol. 2000;49:207\u201314. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00141.x.","journal-title":"J Clin Pharmacol"},{"key":"3138_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/J354v16n04_02","volume":"16","author":"RA Lugo","year":"2002","unstructured":"Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother. 2002;16:5\u201318. https:\/\/doi.org\/10.1080\/J354v16n04_02.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"3138_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1191\/0269216303pm658","volume":"17","author":"C Quigley","year":"2003","unstructured":"Quigley C, et al. Plasma concentrations and effects of morphine and metabolites. Palliat Med. 2003;17:185\u201390. https:\/\/doi.org\/10.1191\/0269216303pm658.","journal-title":"Palliat Med"},{"key":"3138_CR26","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3390\/ijms16022942","volume":"16","author":"JL Koff","year":"2015","unstructured":"Koff JL, et al. Time to kill: targeting apoptosis in cancer. Int J Mol Sci. 2015;16:2942\u201355. https:\/\/doi.org\/10.3390\/ijms16022942.","journal-title":"Int J Mol Sci"},{"key":"3138_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/etm.2016.3346","volume":"12","author":"MI Tian","year":"2016","unstructured":"Tian MI, et al. Comparison of oxycodone and morphine. Exp Ther Med. 2016;12:559\u201366. https:\/\/doi.org\/10.3892\/etm.2016.3346.","journal-title":"Exp Ther Med"},{"key":"3138_CR28","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1742-4658.2009.06938.x","volume":"276","author":"X Lin","year":"2009","unstructured":"Lin X, et al. Chronic high-dose morphine and apoptosis. FEBS J. 2009;276:2022\u201336. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06938.x.","journal-title":"FEBS J"},{"key":"3138_CR29","first-page":"1846","volume":"63","author":"I Tegeder","year":"2003","unstructured":"Tegeder I, et al. G1 cell cycle block and apoptosis with morphine. Cancer Res. 2003;63:1846\u201352.","journal-title":"Cancer Res"},{"key":"3138_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02871-1","author":"L Wang","year":"2023","unstructured":"Wang L, et al. Tramadol suppresses liver tumors via M1 macrophages. Naunyn Schmiedebergs Arch Pharmacol. 2023. https:\/\/doi.org\/10.1007\/s00210-023-02871-1.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3138_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.811716","volume":"12","author":"YH Huang","year":"2022","unstructured":"Huang YH, et al. Antitumor effect of tramadol with doxorubicin. Front Oncol. 2022;12:811716. https:\/\/doi.org\/10.3389\/fonc.2022.811716.","journal-title":"Front Oncol"},{"key":"3138_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bja.2019.09.004","volume":"123","author":"MH Kim","year":"2019","unstructured":"Kim MH, et al. Tramadol and postoperative outcomes in breast cancer. Br J Anaesth. 2019;123:865\u201376. https:\/\/doi.org\/10.1016\/j.bja.2019.09.004.","journal-title":"Br J Anaesth"},{"key":"3138_CR33","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.1038\/s41598-021-01701-9","volume":"11","author":"MH Kim","year":"2021","unstructured":"Kim MH, et al. Antitumor effects of tramadol in mouse breast cancer model. Sci Rep. 2021;11:22113. https:\/\/doi.org\/10.1038\/s41598-021-01701-9.","journal-title":"Sci Rep"},{"key":"3138_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/jcb.24312","volume":"114","author":"W Zhang","year":"2013","unstructured":"Zhang W, et al. Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J Cell Biochem. 2013;114:152\u201361. https:\/\/doi.org\/10.1002\/jcb.24312.","journal-title":"J Cell Biochem"},{"key":"3138_CR35","first-page":"1669","volume":"59","author":"Y Kuraishi","year":"2001","unstructured":"Kuraishi Y. Effects of morphine on cancer pain and tumor growth. Nihon Rinsho. 2001;59:1669\u201374.","journal-title":"Nihon Rinsho"},{"key":"3138_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0014-2999(02)01450-4","volume":"441","author":"T Sasamura","year":"2002","unstructured":"Sasamura T, et al. Morphine suppresses tumor growth in mice. Eur J Pharmacol. 2002;441:185\u201391. https:\/\/doi.org\/10.1016\/S0014-2999(02)01450-4.","journal-title":"Eur J Pharmacol"},{"key":"3138_CR37","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00204-021-03068-2","volume":"95","author":"BA Baldo","year":"2021","unstructured":"Baldo BA. Toxicities of opioid analgesics. Arch Toxicol. 2021;95:2627\u201342. https:\/\/doi.org\/10.1007\/s00204-021-03068-2.","journal-title":"Arch Toxicol"},{"key":"3138_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.18632\/aging.202946","volume":"13","author":"H Dai","year":"2021","unstructured":"Dai H, et al. Morphine may inhibit hepatocellular carcinoma via DDX49. Aging (Albany NY). 2021;13:2\u201314. https:\/\/doi.org\/10.18632\/aging.202946.","journal-title":"Aging (Albany NY)"},{"key":"3138_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.666446","volume":"11","author":"HW Zhang","year":"2021","unstructured":"Zhang HW, et al. Morphine suppresses liver cancer cell properties. Front Oncol. 2021;11:666446. https:\/\/doi.org\/10.3389\/fonc.2021.666446.","journal-title":"Front Oncol"},{"key":"3138_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep11389","volume":"5","author":"S Khabbazi","year":"2015","unstructured":"Khabbazi S, Goumon Y, Parat M-O. Morphine and activation of macrophages by IL-4 or breast cancer cells. Sci Rep. 2015;5:11389. https:\/\/doi.org\/10.1038\/srep11389.","journal-title":"Sci Rep"},{"key":"3138_CR41","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11033-010-0222-z","volume":"38","author":"K Gach","year":"2011","unstructured":"Gach K, et al. Influence of opioids on MMP secretion in MCF-7 cells. Mol Biol Rep. 2011;38:1231\u20136. https:\/\/doi.org\/10.1007\/s11033-010-0222-z.","journal-title":"Mol Biol Rep"},{"key":"3138_CR42","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","volume":"177","author":"L Koodie","year":"2010","unstructured":"Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis. Am J Pathol. 2010;177:984\u201397. https:\/\/doi.org\/10.2353\/ajpath.2010.090621.","journal-title":"Am J Pathol"},{"key":"3138_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bjane.2021.10.019","volume":"73","author":"G Vaseghi","year":"2023","unstructured":"Vaseghi G, et al. Morphine promotes melanoma cell migration. Braz J Anesthesiol. 2023;73:441\u20135. https:\/\/doi.org\/10.1016\/j.bjane.2021.10.019.","journal-title":"Braz J Anesthesiol"},{"key":"3138_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00540-019-02645-1","volume":"33","author":"T Nishiwada","year":"2019","unstructured":"Nishiwada T, et al. Morphine inhibits growth in human oral cancer cells. J Anesth. 2019;33:408\u201315. https:\/\/doi.org\/10.1007\/s00540-019-02645-1.","journal-title":"J Anesth"},{"key":"3138_CR45","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.3390\/ijms22095034","volume":"22","author":"I Karwaciak","year":"2021","unstructured":"Karwaciak I, Salkowska A, Dastych, Ratajewski M. Targeting SIRT2 sensitizes melanoma cells to cisplatin via an EGFR-Dependent Mechanism. Int J Mol Sci. 2021;22:5034. https:\/\/doi.org\/10.3390\/ijms22095034.","journal-title":"Int J Mol Sci"},{"key":"3138_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: the first metal-based anticancer drug. Bioorg Chem. 2019;88:102925. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925.","journal-title":"Bioorg Chem"},{"key":"3138_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/md17020105","volume":"17","author":"JS Barbosa","year":"2019","unstructured":"Barbosa JS, et al. Immunostimulating activity of sulfated polysaccharides from Caulerpa cupressoides. Mar Drugs. 2019;17:105. https:\/\/doi.org\/10.3390\/md17020105.","journal-title":"Mar Drugs"},{"key":"3138_CR48","unstructured":"Sabino VG, Ginani F, Silva TN, Cabral AA, Mota-Filho HG, Freire MCL, Furtado PS, Assump\u00e7\u00e3o PWM, Cabral LM, Moura CE, Rocha HAO, Picciani PHS, Barboza CAG (2020) Laser Therapy"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03138-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:46:16Z","timestamp":1770389176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03138-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03138-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was carried out in accordance with the principles of law no 11794 and the standards of the National Council for Animal Experimentation (CONCEA), Brazil The animal study protocol was approved by the Ethics Committee on the Use of Animals (CEUA\/HUOL) of the Onofre Lopes University Hospital, Federal University of Rio Grande do Norte-UFRN (protocol n\u00ba 001\/2019, approved in March 2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}}],"article-number":"82"}}